ArticleTranslational oncology2025

Response Gene to Complement 32 is associated with poor patient survival and an inflamed tumor-immune microenvironment in clear cell renal cell carcinoma.

Lingling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.